drugset / Trial / NCT00002154

A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia

NCT00002154 ↗

Phase 2 Completed 32 enrolled The Dana Foundation
Double-blindTreatment

Summary

The purpose of this study is to see if it is safe and effective to give thioctic acid and deprenyl (selegiline hydrochloride), alone or in combination, to HIV-infected patients who have mild to moderate dementia (a decline in their mental abilities).

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Thioctic Acid Unknown — —
Subject deprenyl Unknown — —